Abstract:Introduction The study aims to explore the utility of BDNF Val66Met polymorphism as a potential biomarker in Indian bipolar disorder patients and its correlation with clinical characteristics. Objectives Genotyping Val66Met in BDNF gene Exploring its association with bipolar disorder (BD). Methods 150 consenting BD patients and matched controls were recruited using a case-control study design. BD severity was assessed using Young's mania rating scale and the Clinical Global Impression - Severity (CGI-S) scale. BDNF Val66Met polymorphism was identified through real-time PCR after DNA extraction. Data was tested for normal distribution. Genotype frequencies between two groups were compared and the Hardy-Weinberg equilibrium assumptions were tested using Chi-Square tests. Clinical-genotypic associations were explored using the Kruskal-Wallis test and confirmed using hierarchical regression. Results Our sample had more males (60%) than females (40%) with mean age of 35.05 years. Most patients had established bipolar disorder and were severely ill (CGI: 38.75, YMRS). Val66Met SNP genotype frequency differed significantly between cases and controls. Val66Val genotype and Val allele were higher in cases. Results consistent with Hardy-Weinberg equilibrium. Table 1. Genotype frequencies of BDNF (rs6265) in cases and controls GENOTYPE CC CT TT CASES 94(62.6%) 47(31.3%) 9(6%) CONTROL 71(47.3%) 69(46%) 10(6.6%) CHI-SQUARE- 7.431 DF(Degree of freedom) - 2 p-value- 0.024 Table 2. Dominant genotype frequencies in cases and controls DOMINANT GENOTYPE CC CT+TT CASES 94(62.6%) 56(37.3%) CONTROLS 71(47.3%) 79(52.6) CHI-SQUARE-7.125 DF(Degree of freedom)-1 p-value-0.007 Table 3. Allelic frequencies of BDNF (rs6265) in BD cases and healthy controls ALLELIC VARIATION C T CASES 235(78.3%) 65(21.6%) CONTROLS 211(70.3%) 89(29.6%) CHI-SQUARE-5.032 DF(Degree of freedom)-1 p-value- 0.024 Conclusions Our study found that Val66Val genotype and Val allele were higher in cases and could be a potential biomarker for bipolar disorder (BD), which is consistent with previous research conducted on the European population. However, further investigations are required to gain a more comprehensive understanding of its impact on BD, including its association with serum BDNF levels, treatment outcomes, and a more diverse study population. Disclosure of Interest None Declared

The BDNF Val66Met polymorphism serves as a potential marker of body weight in patients with psychiatric disorders

Association Of Brain-Derived Neurotrophic Factor Genetic Val66met Polymorphism With Severity Of Depression, Efficacy Of Fluoxetine And Its Side Effects In Chinese Major Depressive Patients

Association of BDNF Val66Met polymorphism with both baseline HRQOL scores and improvement in HRQOL scores in Chinese major depressive patients treated with fluoxetine.

Association of the BDNF Val66Met Polymorphism with BMI in Chronic Schizophrenic Patients and Healthy Controls

The BDNF gene Val66Met polymorphism as a modifier of psychiatric disorder susceptibility: progress and controversy

BDNF Levels and Genotype Are Associated with Antipsychotic-Induced Weight Gain in Patients with Chronic Schizophrenia

Association Between Brain-Derived Neurotrophic Factor Val66Met Polymorphism and Methamphetamine Use Disorder: A Meta-Analysis

Association of BDNF gene polymorphism with bipolar disorders in Han Chinese population.

Association Between Brain-Derived Neurotrophic Factor Genetic Polymorphism Val66Met and Susceptibility to Bipolar Disorder: a Meta-Analysis

BDNF Val66Met Polymorphism and Anxiety/depression Symptoms in Schizophrenia in a Chinese Han Population.

BDNF Val66Met Polymorphism and Plasma Levels in Chinese Han Population with Obsessive-Compulsive Disorder and Generalized Anxiety Disorder.

Meta-analysis of the association of brain-derived neurotrophic factor Val66Met polymorphism with obsessive-compulsive disorder.

Functional Val66Met polymorphism of Brain-derived neurotrophic factor in type 2 diabetes with depression in Han Chinese subjects

Variant brain-derived neurotrophic factor Val66Met polymorphism alters vulnerability to stress and response to antidepressants

Relationship between a BDNF gene polymorphism and the brain volume in treatment-naive patients with major depressive disorder: A VBM analysis of brain MRI

Positive Association Between the Brain-Derived Neurotrophic Factor (bdnf) Gene and Bipolar Disorder in the Han Chinese Population

Cognitive and Serum Bdnf Correlates of Bdnf Val66met Gene Polymorphism in Patients with Schizophrenia and Normal Controls

Comparison of Val66met Polymorphism of BDNF gene in patients of bipolar disorder and healthy controls.

The relationship between BDNF and physical activity on depression

Effect of brain-derived neurotrophic factor Val66Met polymorphism and environmental factors on antidepressant treatment

Lack of association between BDNF Val66Met gene polymorphism and late-onset depression in a Chinese Han population.